Publication Type
November 10, 2004
Personal Social Security Accounts that Work
The Chief Actuary of Social Security has scored the Ryan-Sununu Social Security reform bill, which provides for large personal retirement accounts, as achieving full and permanent solvency of the program without benefit cuts or tax increases. Eventually there would be substantially higher benefits as well as tax cuts. The unfunded liability of Social Security also would be eliminated.
November 9, 2004
The Cost of Personal Retirement Accounts
It is mistaken to assume that the cost of transitioning to Social Security personal accounts is based on the amount of general revenues that would be needed to finance the transition. This measure, which excludes items that are true costs and includes other items that are not true costs, is biased against personal accounts.
November 4, 2004
Making the World Safe for Idea Pirates
The World Intellectual Property Organization (WIPO) is the most important organization that most people have never heard of.
November 1, 2004
War and Taxes: Inseparably Intertwined
During this campaign season, comparisons of this race to others have been made—often with a great deal of plausibility.
October 28, 2004
The Consumer Project to Stop Technology
Always be skeptical of any organization that calls itself a “consumer group.
October 26, 2004
When “Tax Fairness” Means a Tax Hike
Be careful! The spending lobby—otherwise known as the government—is trying desperately to promote consumption taxes on services as their new revenue source.
October 21, 2004
Who’s Afraid of RFID?
Afraid that your new electronics equipment from Best Buy is spying on you? It’s that tiny chip on the merchandise, hardly big enough see, that transmits radio signals that is causing all the anxiety.
October 12, 2004
The Fertile New Tax Fields of the USA
Little noticed during the presidential campaign was a call by France and Brazil for a system of global taxation to fight poverty.
October 7, 2004
Does America Have a Prescription Drug Problem?: The Perils of Ignoring the Economics of Pharmaceuticals
Critics claim the pharmaceutical industry is unique and therefore requires distinctive forms of regulation, such as price controls. But absent in this view is a systematic appraisal of the economics of the industry. Were their approach adopted, the consequences would be less innovation, fewer life-saving drugs, and a less-healthy citizenry than what could be possible.


